Delivery Order SPE2DB22D3016-SPE2DB25FAQZ1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,067.34. This competitive award, effective September 19, 2025, with an ultimate completion date of September 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $1,472.95. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $1,587.03. This non-set-aside, competitively awarded delivery order was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Adderall XR 20 mg capsules (100 count) with a contract ceiling value of $1,040.94. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count) with a ceiling value of $1,104.99 under a firm fixed-price contract type. The award, issued on May 1, 2025, represents a non-competitive, non-set-aside procurement with an ultimate completion date of May 2, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $1,151.46. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion through December 2026. The place...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $1,648.34. This competitively awarded, firm fixed-price delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Adderall XR 5 mg capsules (100-count units) with a ceiling value of $1,083.01. This firm fixed-price delivery order is scheduled for completion by July 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively without any set-aside designation. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Adderall XR 25 mg capsules (100-count units) valued at $1,828.72. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is expected to be completed by September 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAQZ1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $1,129.20. The contract, which was competitively awarded without set-aside designation, was finalized on March 11, 2025, with an ultimate completion date of March 12, 2025. The firm fixed price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. This prime contract enables AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities on a global basis. AmerisourceBergen's consistent performance across diverse pharmaceutical deliveries demonstrates its capability to support federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/11/25 |